Boosting Demand Of Defibrillators Market Due To Increasing Incidences Of SCA In Younger Population Till 2025


The global defibrillator market is expected to reach USD 18.8 billion by 2025, according to a new report by Grand View Research, Inc. To increase the availability of defibrillators in developed countries, the government is making amendments in their policies to make the product available at various places.

Training programs and awareness campaigns are conducted at regular intervals, which are increasing awareness about defibrillation and indirectly increasing the demand for home care products as well as public access defibrillators.




The healthcare expenditure at a global level is rising, along with increasing penetration of public and private health insurance. This rise is expected to fuel demand for defibrillators across various end-user segments.

Defibrillator market is driven by innovative processes. For instance, a program under trial in Sweden is likely to deliver AEDs via drones. This is anticipated to reduce the delivery time for defibrillators, thus saving more lives. The growth of this industry can be attributed to new product development, mergers & acquisitions, and rising market penetration.

Browse full research report on Defibrillators Market: www.grandviewresearch.com/industry-analysis/defibrillators-market    

Further Key findings from the study suggest:

  • Implantable Convertible Defibrillator (ICD) was the major contributor in the defibrillator industry in 2016
  • External defibrillators recorded the fastest growth in the industry
  • Hospitals were the major contributors in the end-use segment in 2016
  • The public access market was the fastest growing end-user segment of the overall defibrillator industry in 2016
  • North America held a major market share of the defibrillator industry
  • Asia Pacific region is anticipated to exhibit fastest growth in the global defibrillator industry
  • Some of the key players are Medtronic; St. Jude Medical LLC; Boston Scientific Corporation; LivaNova; Koninklijke Philips N.V.; ZOLL Medical Corporation; Cardiac Science; Physio-Control Inc.; Nihon Kohden Corporation; Defibtech LLC; HeartSine Technologies LLC; Progetti Srl; Fukuda Denshi Co., Ltd.; and Schiller AG
  • New product development, mergers & acquisitions, and regional expansion are some of the strategic initiatives undertaken by the key players

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices 

                                                                                                                                           
Grand View Research has segmented the defibrillator market report by product, end-use, and region:

 Defibrillator Product Outlook (Revenue, USD Million; 2014 - 2025)
  • Implantable Cardioverter Defibrillator
    • S-ICD
    • T-ICD
      • CRT-D
      • Single Chamber
      • Dual Chamber
  • External Defibrillator (ED)
    • Manual ED
    • Automated ED
    • Wearable Cardioverter Defibrillator
Defibrillator End-use Outlook (Revenue, USD Million; 2014 - 2025)
  • Hospital
  • Prehospital
  • Public Access Market
  • Alternate Care Market
  • Home Healthcare
Defibrillator Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-defibrillators-market                                                                                                         

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more